Eli Lilly & Co. has updated the label of Trulicity, a drug used to help control Type 2 diabetes, to state that the drug may be used in combination with insulin.
The FDA approved the change.
“Despite best efforts to manage the A1C, many adults with Type 2 diabetes may need to add to or change their treatment plan to help them reach their blood sugar goals,” Sherry Martin, vice president of Global Medical Affairs at Eli Lilly, said. “They now have the option to use Trulicity with its powerful efficacy in a weekly, easy to use pen along with insulin for even greater control.”
Eli Lilly also stated Trucility is not a replacement for insulin.
Eli Lilly updates label for Trulicity
Alerts Sign-up